Suchergebnisse
Suchergebnisse:
Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients … S Kaatz, D Ahmad, AC...
Alex C. Spyropoulos, MD, FACP, FCCP, FRCPC. Professor, Institute of Health System Science, Feinstein Institutes for Medical Research. Director, Anticoagulation and Clinical Thrombosis Services, Northwell Health. Professor, Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. (212) 434-6779.
He is the lead investigator in a large thromboembolic outcome study of over 10.871 hospitalized COVID-19 patients at Northwell Health. He has published over 10 articles, editorials, and letters for major journals related to COVID-19 and thrombosis.
27. Juni 2021 · These events encompassed both arterial and venous thromboembolic events (ATEs and VTEs), including four non–ST-segment–elevation myocardial infarctions, three pulmonary emboli, one ischemic stroke, and one splenic infarct. Approximately 42% of patients were discharged on prophylactic anticoagulation, mostly direct oral ...
- Alex C. Spyropoulos, Alex C. Spyropoulos, Dimitrios Giannis, Mark Goldin, Mark Goldin, Mark Goldin
- 2021
Ongoing randomized trials that address key clinical questions, especially more intense thromboprophylactic strategies and novel antithrombotic approaches, have the potential to reduce the morbidity and mortality from VTE in hospitalized and critically ill patients with COVID-19.
He is the lead investigator in a large thromboembolic outcome study of over 10.871 hospitalized COVID-19 patients at Northwell Health. He has published over 10 articles, editorials, and letters for major journals related to COVID-19 and thrombosis.
Alex C Spyropoulos View Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With...
